BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 18524667)

  • 1. Troy/Taj and its role in CNS axon regeneration.
    Mi S
    Cytokine Growth Factor Rev; 2008; 19(3-4):245-51. PubMed ID: 18524667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TAJ/TROY, an orphan TNF receptor family member, binds Nogo-66 receptor 1 and regulates axonal regeneration.
    Shao Z; Browning JL; Lee X; Scott ML; Shulga-Morskaya S; Allaire N; Thill G; Levesque M; Sah D; McCoy JM; Murray B; Jung V; Pepinsky RB; Mi S
    Neuron; 2005 Feb; 45(3):353-9. PubMed ID: 15694322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A TNF receptor family member, TROY, is a coreceptor with Nogo receptor in mediating the inhibitory activity of myelin inhibitors.
    Park JB; Yiu G; Kaneko S; Wang J; Chang J; He XL; Garcia KC; He Z
    Neuron; 2005 Feb; 45(3):345-51. PubMed ID: 15694321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LINGO-1 antagonist promotes functional recovery and axonal sprouting after spinal cord injury.
    Ji B; Li M; Wu WT; Yick LW; Lee X; Shao Z; Wang J; So KF; McCoy JM; Pepinsky RB; Mi S; Relton JK
    Mol Cell Neurosci; 2006 Nov; 33(3):311-20. PubMed ID: 17011208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developmental analysis of Lingo-1/Lern1 protein expression in the mouse brain: interaction of its intracellular domain with Myt1l.
    Llorens F; Gil V; Iraola S; Carim-Todd L; Martí E; Estivill X; Soriano E; del Rio JA; Sumoy L
    Dev Neurobiol; 2008 Mar; 68(4):521-41. PubMed ID: 18186492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex.
    Mi S; Lee X; Shao Z; Thill G; Ji B; Relton J; Levesque M; Allaire N; Perrin S; Sands B; Crowell T; Cate RL; McCoy JM; Pepinsky RB
    Nat Neurosci; 2004 Mar; 7(3):221-8. PubMed ID: 14966521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AMIGO3 is an NgR1/p75 co-receptor signalling axon growth inhibition in the acute phase of adult central nervous system injury.
    Ahmed Z; Douglas MR; John G; Berry M; Logan A
    PLoS One; 2013; 8(4):e61878. PubMed ID: 23613963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TROY and LINGO-1 expression in astrocytes and macrophages/microglia in multiple sclerosis lesions.
    Satoh J; Tabunoki H; Yamamura T; Arima K; Konno H
    Neuropathol Appl Neurobiol; 2007 Feb; 33(1):99-107. PubMed ID: 17239012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression profile of receptors for myelin-associated inhibitors of axonal regeneration in the intact and injured mouse central nervous system.
    Barrette B; Vallières N; Dubé M; Lacroix S
    Mol Cell Neurosci; 2007 Apr; 34(4):519-38. PubMed ID: 17234430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myelin-, reactive glia-, and scar-derived CNS axon growth inhibitors: expression, receptor signaling, and correlation with axon regeneration.
    Sandvig A; Berry M; Barrett LB; Butt A; Logan A
    Glia; 2004 May; 46(3):225-51. PubMed ID: 15048847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations of p75 neurotrophin receptor and Myelin transcription factor 1 in the hippocampus of perinatal phencyclidine treated rats.
    Andrews JL; Newell KA; Matosin N; Huang XF; Fernandez-Enright F
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Dec; 63():91-7. PubMed ID: 26071990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p75 neurotrophin receptor signaling in the nervous system.
    Hasegawa Y; Yamagishi S; Fujitani M; Yamashita T
    Biotechnol Annu Rev; 2004; 10():123-49. PubMed ID: 15504705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TROY, a novel member of the tumor necrosis factor receptor superfamily in the central nervous system.
    Morikawa Y; Hisaoka T; Kitamura T; Senba E
    Ann N Y Acad Sci; 2008 Apr; 1126():A1-10. PubMed ID: 18584774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ganglioside mediate the interaction between Nogo receptor 1 and LINGO-1.
    Saha N; Kolev MV; Semavina M; Himanen J; Nikolov DB
    Biochem Biophys Res Commun; 2011 Sep; 413(1):92-7. PubMed ID: 21872576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Axon regeneration: it's getting crowded at the gates of TROY.
    Mandemakers WJ; Barres BA
    Curr Biol; 2005 Apr; 15(8):R302-5. PubMed ID: 15854897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TROY interacts with Rho guanine nucleotide dissociation inhibitor α (RhoGDIα) to mediate Nogo-induced inhibition of neurite outgrowth.
    Lu Y; Liu X; Zhou J; Huang A; Zhou J; He C
    J Biol Chem; 2013 Nov; 288(47):34276-34286. PubMed ID: 24129566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased hippocampal NgR1 signaling machinery in aged rats with deficits of spatial cognition.
    VanGuilder Starkey HD; Sonntag WE; Freeman WM
    Eur J Neurosci; 2013 May; 37(10):1643-58. PubMed ID: 23438185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of TROY/TNFRSF19/TAJ-expressing cells in the adult mouse forebrain.
    Hisaoka T; Morikawa Y; Senba E
    Brain Res; 2006 Sep; 1110(1):81-94. PubMed ID: 16870160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging functions of myelin-associated proteins during development, neuronal plasticity, and neurodegeneration.
    Llorens F; Gil V; del Río JA
    FASEB J; 2011 Feb; 25(2):463-75. PubMed ID: 21059749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The p75 receptor acts as a displacement factor that releases Rho from Rho-GDI.
    Yamashita T; Tohyama M
    Nat Neurosci; 2003 May; 6(5):461-7. PubMed ID: 12692556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.